Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver.

about

Rebamipide: A Novel Agent in the Treatment of Recurrent Aphthous Ulcer and Behcet's Syndrome.Rebamipide: a gastrointestinal protective drug with pleiotropic activities.

P2860

Q42121542-C83E368A-D169-47C1-B8E6-33D1C480B60E Q43042896-375C5B48-31FA-47AB-BA0F-E4511DA1B3F3

P2860

Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver.

Item

http://www.wikidata.org/entity/Q44090134

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver.

@en

Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver.

@nl

type

Item

label

Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver.

@en

Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver.

@nl

prefLabel

Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver.

@en

Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver.

@nl

P1476

Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver.

@en

P2093

G Miyamoto

http://www.w3.org/2001/XMLSchema#string

H Sasabe

http://www.w3.org/2001/XMLSchema#string

N Koyama

http://www.w3.org/2001/XMLSchema#string

P2860

Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme

Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects

Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae

Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms.

Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae.

Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin.

Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.

Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats.

P304

573-586

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00498250210130591

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12162853

http://www.w3.org/2001/XMLSchema#string

Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver.

about

P2860

P2860

Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698